bibliographicCitation |
Zachos I, Konstantinopoulos PA, Vandoros GP, Karamouzis MV, Papatsoris AG, Podimatas T, Papachristodoulou A, Chrisofos M, Deliveliotis C, Papavassiliou AG. Predictive value of telomerase reverse transcriptase expression in patients with high risk superficial bladder cancer treated with adjuvant BCG immunotherapy. Journal of Cancer Research and Clinical Oncology. 2009 Feb 12;135(9):1169–75. doi: 10.1007/s00432-009-0557-9. |